Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

10.73
-0.2200-2.01%
Post-market: 10.730.00000.00%18:30 EDT
Volume:148.26K
Turnover:1.60M
Market Cap:536.51M
PE:-9.05
High:11.04
Open:11.00
Low:10.67
Close:10.95
Loading ...
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 15, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 11, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jun 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
May 03, 2023

Major Issues Report

8-K - Current report
Apr 17, 2023

Major Issues Report

8-K - Current report
Apr 14, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 12, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 11, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report